Discovery Platform for Deep Target Mining of Tractable Targets for the Development of First-in-Class Therapeutics for Neuroendocrine Prostate Cancer
David S. Rickman, Associate Professor of Pathology and Laboratory Medicine
Innovative Personalized Medicine Platform that Recapitulates the Human Immune System for the Development of Novel Oncology Therapeutics
Giorgio Inghirami, Professor of Pathology and Laboratory Medicine
Identification and Development of Novel Antifungal Drugs for Treatment of Gastrointestinal Fungal Infections
Iliyan D. Iliev, Associate Professor of Immunology in Medicine
Development of Next Generation Therapeutics for NAFLD/NASH
Olivier Elemento, Director of the Englander Institute for Precision Medicine
High-Throughput Identification of Novel Treatments for Liver Cirrhosis and Hepatocarcinoma
Olivier Elemento, Director of the Englander Institute for Precision Medicine
Novel Machine Learning Approach to Systematically Predict Drug Severe Adverse Events
Olivier Elemento, Director of the Englander Institute for Precision Medicine
Novel Gene Therapy Platform for the Treatment and Accelerated Healing of Orthopedic Injuries
Ronald Crystal, Professor and Chair of Genetic Medicine
Deep Target Mining for the Development of First-in-Class Therapeutics to Treat COPD
Ronald Crystal, Professor and Chair of Genetic Medicine
Enhancing the Therapeutic Potential of mTOR Inhibitors in Breast Cancer: Overcoming Therapy Resistance in TNBC
John Blenis, Anna-Maria and Stephen Kellen Professor in Cancer Research
Targeting Metabolic Pathways that Play a Role in Longevity and Cancer
John Blenis, Anna-Maria and Stephen Kellen Professor in Cancer Research